Breaking News: Morgan Stanley Halts Financing for Karo Deal Amid Market Volatility

In a significant shift in the financial landscape, Morgan Stanley has decided to withdraw its financing support for the Karo Pharma acquisition deal. This move comes during a period of notable market instability and raises questions about the future of the deal and its ramifications for stakeholders involved.

Continue reading